FGFR1 — Drug Target

All drugs that target FGFR1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

FGFR1 inhibitor

Phase 3 pipeline (1)

• AZD5335 · AstraZeneca · FGFR1 inhibitor · Oncology
  AZD5335 is a selective inhibitor of fibroblast growth factor receptor 1 (FGFR1) that blocks aberrant FGFR signaling in cancer cells.

Phase 2 pipeline (1)

• FGF-2 · NYU Langone Health · Cardiovascular
  FGF-2 is a fibroblast growth factor that promotes angiogenesis and tissue repair.